JP2006501825A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006501825A5 JP2006501825A5 JP2004541707A JP2004541707A JP2006501825A5 JP 2006501825 A5 JP2006501825 A5 JP 2006501825A5 JP 2004541707 A JP2004541707 A JP 2004541707A JP 2004541707 A JP2004541707 A JP 2004541707A JP 2006501825 A5 JP2006501825 A5 JP 2006501825A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- cervical cancer
- nucleic acid
- immunogenic composition
- administering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 14
- 102000004196 processed proteins & peptides Human genes 0.000 claims 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims 14
- 206010008342 Cervix carcinoma Diseases 0.000 claims 6
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 6
- 201000010881 cervical cancer Diseases 0.000 claims 6
- 230000002163 immunogen Effects 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 239000013604 expression vector Substances 0.000 claims 4
- 230000028993 immune response Effects 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 230000001681 protective effect Effects 0.000 claims 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 230000035772 mutation Effects 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 239000004471 Glycine Substances 0.000 claims 1
- 241000701806 Human papillomavirus Species 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 241000710959 Venezuelan equine encephalitis virus Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41592902P | 2002-10-03 | 2002-10-03 | |
| US60/415,929 | 2002-10-03 | ||
| PCT/US2003/031726 WO2004030636A2 (en) | 2002-10-03 | 2003-10-02 | Human papillomavirus polypeptides and immunogenic compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010181424A Division JP5398665B2 (ja) | 2002-10-03 | 2010-08-13 | ヒトパピローマウイルス・ポリペプチドおよび免疫原性組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006501825A JP2006501825A (ja) | 2006-01-19 |
| JP2006501825A5 true JP2006501825A5 (enExample) | 2006-11-16 |
| JP4755422B2 JP4755422B2 (ja) | 2011-08-24 |
Family
ID=32069921
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004541707A Expired - Lifetime JP4755422B2 (ja) | 2002-10-03 | 2003-10-02 | ヒトパピローマウイルス・ポリペプチドおよび免疫原性組成物 |
| JP2010181424A Expired - Lifetime JP5398665B2 (ja) | 2002-10-03 | 2010-08-13 | ヒトパピローマウイルス・ポリペプチドおよび免疫原性組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010181424A Expired - Lifetime JP5398665B2 (ja) | 2002-10-03 | 2010-08-13 | ヒトパピローマウイルス・ポリペプチドおよび免疫原性組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7223408B2 (enExample) |
| EP (1) | EP1553966B1 (enExample) |
| JP (2) | JP4755422B2 (enExample) |
| KR (1) | KR101145190B1 (enExample) |
| CN (1) | CN1720060B (enExample) |
| AU (1) | AU2003282731B2 (enExample) |
| BR (1) | BR0314529A (enExample) |
| CA (1) | CA2499837C (enExample) |
| CO (1) | CO5700784A2 (enExample) |
| DK (1) | DK1553966T3 (enExample) |
| ES (1) | ES2391451T3 (enExample) |
| MX (1) | MXPA05003395A (enExample) |
| NZ (1) | NZ556544A (enExample) |
| PT (1) | PT1553966E (enExample) |
| WO (1) | WO2004030636A2 (enExample) |
| ZA (1) | ZA200502618B (enExample) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8128922B2 (en) | 1999-10-20 | 2012-03-06 | Johns Hopkins University | Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
| EP1363938B1 (en) | 2000-08-03 | 2013-12-11 | Johns Hopkins University | Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| CA2499837C (en) * | 2002-10-03 | 2013-12-03 | Wyeth Holdings Corporation | Human papillomavirus polypeptides and immunogenic compositions |
| EP1644048B1 (en) | 2003-05-05 | 2015-04-29 | Johns Hopkins University | Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein |
| US8399610B2 (en) * | 2004-08-05 | 2013-03-19 | University College Cardiff Consultants Limited | HPV vaccine comprising peptides from host cell proteins |
| GB0417430D0 (en) * | 2004-08-05 | 2004-09-08 | Uc3 | A novel HPV vaccine comprising peptides from host cell proteins |
| JP4474264B2 (ja) | 2004-08-20 | 2010-06-02 | 生寶生物科技股▲ふん▼有限公司 | 子宮頸癌抑制の融合蛋白 |
| ATE476528T1 (de) | 2004-12-08 | 2010-08-15 | Gen Probe Inc | Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus |
| WO2006073970A2 (en) | 2005-01-06 | 2006-07-13 | The Johns Hopkins University | Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines |
| JP2008526248A (ja) * | 2005-01-14 | 2008-07-24 | ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン | 生体試料におけるヒトパピローマウイルス検出のためのシステム、方法、および組成 |
| WO2006081323A2 (en) * | 2005-01-26 | 2006-08-03 | The Johns Hopkins University | Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin |
| US8137674B2 (en) | 2006-04-19 | 2012-03-20 | Postech Foundation | Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer |
| US9085638B2 (en) | 2007-03-07 | 2015-07-21 | The Johns Hopkins University | DNA vaccine enhancement with MHC class II activators |
| EP2162149B1 (en) * | 2007-06-01 | 2013-11-06 | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Vaccine for the prevention of breast cancer relapse |
| US20090117123A1 (en) * | 2007-11-02 | 2009-05-07 | National Health Research Institutes | Immunopeptides of hpv e6 and e7 proteins |
| US20120121715A1 (en) * | 2008-01-02 | 2012-05-17 | National Taiwan University | DNA Vaccine Comprising IL-6-Encoding DNA Construct and Applications Thereof |
| EP2335730A1 (en) * | 2009-12-18 | 2011-06-22 | Deutsches Krebsforschungszentrum | Fusion polypeptides and their use for prevention and treatment of cancer |
| KR101197627B1 (ko) * | 2010-01-18 | 2012-11-07 | (주)레퍼런스바이오랩 | Ｈｐｖ 감염과 관련된 암의 치료용 조성물 |
| CA2981303C (en) * | 2010-02-16 | 2020-06-30 | Becton, Dickinson And Company | Assay for detecting closely-related serotypes of human papillomavirus (hpv) |
| CA2799205A1 (en) | 2010-05-25 | 2011-12-01 | Qiagen Gaithersburg, Inc. | Fast results hybrid capture assay and associated strategically-truncated probes |
| WO2012020871A1 (ko) * | 2010-08-13 | 2012-02-16 | 주식회사 제넥신 | 사람 파필로마바이러스 변형체 및 면역 증강제를 포함하는 자궁경부암 예방 또는 치료용 조성물 |
| KR102373828B1 (ko) * | 2011-10-12 | 2022-03-14 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 인간 파필로마 바이러스에 대한 백신 및 이것을 사용하는 방법 |
| EP3533462A1 (en) * | 2011-12-21 | 2019-09-04 | Vaccibody AS | Vaccines against hpv |
| CN104159607A (zh) | 2012-01-24 | 2014-11-19 | 桑福德研究院/南达科他大学 | 用于治疗致癌病毒多肽阳性肿瘤的多核苷酸 |
| CN103288931B (zh) * | 2012-02-24 | 2015-05-27 | 宋硕 | 人类乳头瘤病毒免疫原性多肽、其制备方法及应用 |
| WO2014165291A1 (en) | 2013-03-12 | 2014-10-09 | The Trustees Of The University Of Pennsylvania | Improved vaccines for human papilloma virus and methods for using the same |
| MX428954B (es) * | 2013-03-15 | 2025-11-13 | Univ Pennsylvania | Vacunación mejorada contra la hormona liberadora de la hormona de crecimiento (ghrh) humana. |
| CN107073070A (zh) | 2014-08-15 | 2017-08-18 | 格纳西尼有限公司 | 治疗宫颈癌的方法 |
| JP5973007B2 (ja) * | 2015-01-30 | 2016-08-17 | ジェネクサイン・インコーポレーテッド | ヒトパピローマウイルス変形体及び免疫増強剤を含む子宮頸癌の予防または治療用組成物 |
| SMT202100467T1 (it) | 2015-04-17 | 2021-09-14 | Alpine Immune Sciences Inc | Proteine immunomodulatorie con affinità regolabili |
| HK1246183A1 (zh) * | 2015-06-10 | 2018-09-07 | Hookipa Biotech Gmbh | Hpv疫苗 |
| WO2017060360A1 (en) * | 2015-10-06 | 2017-04-13 | Invectys | Polyepitope constructs for use in immunotherapy |
| JP2019505512A (ja) | 2016-01-08 | 2019-02-28 | バッシボディ アクスイェ セルスカプ | 治療用抗癌ネオエピトープワクチン |
| SG11201808457PA (en) | 2016-04-15 | 2018-10-30 | Alpine Immune Sciences Inc | Icos ligand variant immunomodulatory proteins and uses thereof |
| AU2017248830B2 (en) | 2016-04-15 | 2023-03-09 | Alpine Immune Sciences, Inc. | CD80 variant immunomodulatory proteins and uses thereof |
| EP3491013A1 (en) | 2016-07-28 | 2019-06-05 | Alpine Immune Sciences, Inc. | Cd155 variant immunomodulatory proteins and uses thereof |
| WO2018060288A1 (en) | 2016-09-29 | 2018-04-05 | Glaxosmithkline Biologicals S.A. | Compositions and methods of treatment of persistent hpv infection |
| CN106632694B (zh) * | 2017-01-24 | 2021-02-12 | 南京益康生物医药有限公司 | 一种重组蛋白及药物组合物与应用 |
| CN110719788A (zh) * | 2017-04-07 | 2020-01-21 | 霍欧奇帕生物科技有限公司 | 治疗实体瘤的沙粒病毒颗粒 |
| EP3461497A1 (en) * | 2017-09-27 | 2019-04-03 | GlaxoSmithKline Biologicals S.A. | Viral antigens |
| EP3694870A1 (en) | 2017-10-10 | 2020-08-19 | Alpine Immune Sciences, Inc. | Ctla-4 variant immunomodulatory proteins and uses thereof |
| JP7282760B2 (ja) | 2017-10-18 | 2023-05-29 | アルパイン イミューン サイエンシズ インコーポレイテッド | バリアントｉｃｏｓリガンド免疫調節タンパク質ならびに関連する組成物および方法 |
| CN113727998A (zh) | 2018-11-30 | 2021-11-30 | 高山免疫科学股份有限公司 | Cd86变体免疫调节蛋白及其用途 |
| WO2021026335A1 (en) * | 2019-08-08 | 2021-02-11 | The Trustees Of Indiana University | Methods for identifying and treating urinary tract infections |
| WO2021205027A1 (en) | 2020-04-09 | 2021-10-14 | Vaccibody As | Individualized therapeutic anticancer vaccine |
| MX2022013063A (es) | 2020-04-24 | 2022-12-08 | Genexine Inc | Metodo para tratamiento del cancer cervicouterino. |
| US12202882B2 (en) | 2020-05-08 | 2025-01-21 | Alpine Immune Sciences, Inc. | APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof |
| CN114478712B (zh) * | 2022-03-29 | 2022-09-23 | 深圳吉诺因生物科技有限公司 | Hpv抗原表位及其鉴定方法、应用 |
| WO2024145863A1 (en) * | 2023-01-05 | 2024-07-11 | Virogin Biotech (Shanghai) Ltd. | A NOVEL mRNA VACCINE FOR THE TREATMENT AND PREVENTION OF HPV-ASSOCIATED LESIONS AND TUMORS |
| CN117925916A (zh) * | 2024-03-11 | 2024-04-26 | 广州市金域转化医学研究院有限公司 | Hpv dna的e6基因在制备浸润性宫颈癌诊断产品中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9105383D0 (en) | 1991-03-14 | 1991-05-01 | Immunology Ltd | An immunotherapeutic for cervical cancer |
| AUPN015794A0 (en) * | 1994-12-20 | 1995-01-19 | Csl Limited | Variants of human papilloma virus antigens |
| AUPN443995A0 (en) * | 1995-07-27 | 1995-08-17 | Csl Limited | Papillomavirus polyprotein |
| GB9717953D0 (en) * | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
| CN1433428A (zh) * | 2000-04-05 | 2003-07-30 | 冲击诊断公司 | 辨别人乳头瘤病毒的免疫学方法 |
| CA2499837C (en) * | 2002-10-03 | 2013-12-03 | Wyeth Holdings Corporation | Human papillomavirus polypeptides and immunogenic compositions |
-
2003
- 2003-10-02 CA CA2499837A patent/CA2499837C/en not_active Expired - Lifetime
- 2003-10-02 BR BR0314529-8A patent/BR0314529A/pt not_active Application Discontinuation
- 2003-10-02 NZ NZ556544A patent/NZ556544A/en unknown
- 2003-10-02 PT PT03774615T patent/PT1553966E/pt unknown
- 2003-10-02 AU AU2003282731A patent/AU2003282731B2/en not_active Expired
- 2003-10-02 EP EP03774615A patent/EP1553966B1/en not_active Expired - Lifetime
- 2003-10-02 US US10/530,253 patent/US7223408B2/en not_active Expired - Lifetime
- 2003-10-02 ES ES03774615T patent/ES2391451T3/es not_active Expired - Lifetime
- 2003-10-02 DK DK03774615.3T patent/DK1553966T3/da active
- 2003-10-02 CN CN200380104973XA patent/CN1720060B/zh not_active Expired - Lifetime
- 2003-10-02 JP JP2004541707A patent/JP4755422B2/ja not_active Expired - Lifetime
- 2003-10-02 KR KR1020057005780A patent/KR101145190B1/ko not_active Expired - Lifetime
- 2003-10-02 MX MXPA05003395A patent/MXPA05003395A/es active IP Right Grant
- 2003-10-02 WO PCT/US2003/031726 patent/WO2004030636A2/en not_active Ceased
-
2005
- 2005-03-31 ZA ZA200502618A patent/ZA200502618B/xx unknown
- 2005-04-28 CO CO05040563A patent/CO5700784A2/es unknown
-
2007
- 2007-01-26 US US11/627,697 patent/US7378099B2/en not_active Expired - Lifetime
-
2010
- 2010-08-13 JP JP2010181424A patent/JP5398665B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006149406A5 (enExample) | ||
| JP2006187292A5 (enExample) | ||
| JP2017513502A5 (enExample) | ||
| JP2023512519A5 (enExample) | ||
| JP2001081042A5 (enExample) | ||
| JP2014527404A5 (enExample) | ||
| JP2004504057A5 (enExample) | ||
| JP2002510494A5 (enExample) | ||
| JP2004532023A5 (enExample) | ||
| JP2008529558A5 (enExample) | ||
| JP2005523318A5 (enExample) | ||
| JPH09322781A5 (enExample) | ||
| JP2004511201A5 (enExample) | ||
| JP2008530245A5 (enExample) | ||
| JP2005505286A5 (enExample) | ||
| JP2002542827A5 (enExample) | ||
| JP2002503683A5 (enExample) | ||
| JP2004531242A5 (enExample) | ||
| CA2505942A1 (en) | West nile virus vaccine | |
| JP2004537308A5 (enExample) | ||
| WO2004085633A8 (en) | A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof | |
| KR20200027956A (ko) | 키메라 바이러스-유사 입자 및 면역 반응의 항원-특이적 재지향자로서의 이의 용도 | |
| RU2005113692A (ru) | Вакцина против hcv | |
| JP2002539781A5 (enExample) | ||
| JP2004537284A5 (enExample) |